Federal Circuit Precedential Opinion Sheds Light on Importance of Issues Presented On Appeal
Just Skinny Enough: District Court Dismisses Inducement Claims Against Generic “Skinny Label”
The Federal Circuit Finds IPR Petitioner Has Standing
Federal Circuit Panel Rehears Skinny Label Case (GSK v. Teva)
Federal Circuit Grants Remand in Ex Parte Reexam While World Waits for Supreme Court to Weigh in on Arthrex
Delays, Denials and Uncertainty: Developments in the Arthrex Redo Case Line
The Federal Circuit Dismisses Pfizer’s Appeal for Lack of Standing
Committee for Medicinal Products for Human Use Provides Biosimilar Updates at March Meeting
